Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Price

GPCRStock
$49.92+149.92%52W
Market Cap$3.56B
P/E
PEG Ratio
Div yield
Beta-1.67

GPCR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.55%
Price vs S&P 500 (4W)-0.71%
VGM Score62.92

GPCR Earnings Surprise History

Q2 25-0.36est. -0.28
Q3 25-0.37est. -0.37
Q4 250.20est. -0.37
Q1 26-0.35est. -0.31
Q2 26-0.49est. -0.38

GPCR Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.25
4.25
4.26

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
GPCRStructure Therapeutics Inc. American Depositary Shares
B$49.92
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule therapeutics targeting G-protein coupled receptors (GPCRs) for chronic diseases with unmet medical needs. The company's differentiated platform integrates structure-based drug discovery with computational chemistry expertise to advance its pipeline of potential medicines.